-+ 0.00%
-+ 0.00%
-+ 0.00%

BioPharma Credit Enters $45 Million Senior Loan Deal for Kestra Medical Technologies Investment

MT Newswires·07/15/2026 04:11:12
Listen to the news
04:11 AM EDT, 07/15/2026 (MT Newswires) -- BioPharma Credit (BPCP.L, BPCR.L) will invest up to $45 million in Kestra Medical Technologies under a three-tranche senior secured loan deal. The British life sciences debt investment trust said Wednesday that the loan, which will mature in July 2031, will carry an annual interest rate of a three-month Secured Overnight Financing Rate, or SOFR, plus 5.50%, subject to a 3.25% SOFR floor. BioPharma Credit said the investments for the wearable medical device and digital healthcare company will be subject to customary requirements. Additionally, the company's BioPharma Credit Investments V (Master) unit will also act as a collateral agent for an additional $105 million investment.